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Wound infection presents a challenging and growing problem. With the increased prevalence and growth of
multidrug-resistant bacteria, there is a mounting need to reduce and eliminate wound infections using meth-
odologies that limit the ability of bacteria to evolve into further drug-resistant strains. A well-known strategy for
combating bacterial infection and preventing wound sepsis is through the delivery of silver ions to the wound
site. High surface area silver nanoparticles (AgNPs) allowing extensive silver ion release have therefore been
explored in different wound dressings and/or skin substitutes. However, it has been recently shown that AgNPs
can penetrate into the stratum corneum of skin or diffuse into the cellular plasma membrane, and may interfere
with a variety of cellular mechanisms. The goal of this study was to introduce and evaluate a new type of high
surface area metallic silver in the form of highly porous silver microparticles (AgMPs). Polylactic acid (PLA)
nanofibers were successfully loaded with either highly porous AgMPs or AgNPs and the antimicrobial efficacy
and cytotoxicity of the two silver-based wound dressings were assessed and compared. To better mimic the
physiological environment in vivo where both human cells and bacteria are present, a novel coculture system
combining human epidermal keratinocytes and Staphylococcus aureus bacteria was designed to simultaneously
evaluate human skin cell cytotoxicity with antimicrobial efficacy in a three-dimensional environment. We
found that highly porous AgMPs could be successfully incorporated in nanofibrous wound dressings, and
exhibited comparable antimicrobial efficacy and cytotoxicity to AgNPs. Further, PLA nanofibers containing
highly porous AgMPs exhibited steady silver ion release, at a greater rate of release, than nanofibers containing
AgNPs. The replacement of AgNPs with the newly introduced AgMPs overcomes concerns regarding the use of
nanoparticles and holds great promise as skin substitutes or wound dressings for infected wound sites.
Introduction
Wound infection presents a challenging and grow-ing problem, in particular, for those individuals with
compromised immune systems. Wound infection delays
wound closure,1,2 diminishes tensile strength of the healing
wound tissue, increases the length of hospital stay and costs,
and increases the patient’s risk of bacteremia, sepsis, multi-
system organ failure, and death.3 With the increased preva-
lence and growth of multidrug-resistant bacteria, there is
mounting need to reduce and eliminate wound infection using
methodologies that limit the ability of bacteria to evolve into
further drug-resistant strains. A well-known strategy for
combating bacterial infection and preventing wound sepsis is
through delivery of silver ions to the wound site.4 Silver ions
can be introduced to infected wound sites by a number of
different mechanisms. A well-known technique is utilization
of silver salt solutions, the most effective of which is silver
nitrate (AgNO3).
5 Aqueous silver nitrate at a concentration of
0.5% has been shown effective as a topical treatment for burn
patients.5 Silver nitrate is usually applied to the wound site by
wetting cotton gauze dressings with silver nitrate solution
every 3–4 h per day.6 Other forms of silver have been inves-
tigated, in particular, silver sulfadiazine. Silver sulfadiazine is
also delivered topically to burn wounds, typically in a 1%
cream or suspension.7 Silver sulfadiazine provides a sufficient
concentration of silver and its residual activity is higher than
silver nitrate, allowing for application only twice per day.
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Whereas both these approaches have proven successful
for their antimicrobial and antibacterial attributes, they lack
the ability for continued release of silver ions, requiring
constant reapplication of the compound to painful wound
sites. The large, rapid release of silver ions from silver
nitrate and silver sulfadiazine can also have negative effects
on the host cells, as explained later in this article. Therefore,
interest has grown in methods to deliver silver ions con-
tinuously, without constant reapplication of the silver-
containing compound. A recent technique to address this
challenge is to incorporate metallic silver in wound dress-
ings.8 When the wound dressings are exposed to fluids in
the wound bed and tissue exudates, a sustained release of
silver ions occurs.9 The total amount of silver ions that can
be released from metallic silver depends on the available
surface area.10,11 High surface area silver nanoparticles
(AgNPs) allowing extensive silver ion release have there-
fore been explored in different wound dressings and/or skin
substitutes.8 Their excellent antimicrobial efficacy has been
shown; however, concern has grown regarding the release
of AgNPs from different products into the environment. It
is now known that AgNPs can penetrate into the stratum
corneum of skin12,13 or even diffuse into the cellular plasma
membrane, and interfere with a variety of cellular mecha-
nisms.14,15 The ability to harness the antimicrobial benefits
of high surface area metallic silver in wound dressings,
without the use of AgNPs, remains a significant challenge.
A solution has yet to be determined.
When implementing silver in wound dressings, the cyto-
toxicity of the dressings to the host cells is as important a
component of their fabrication as their antimicrobial prop-
erties. Although it has been traditionally reported that silver
causes low mammalian cell toxicity,16,17 silver ions do have
cytotoxic effects on some mammalian cells. It has been
shown that epidermal keratinocytes and dermal fibroblasts,
the two dominant cell types in human skin, are susceptible
to lethal damage when exposed to high concentrations of
silver.18 However, since cytotoxicity is directly proportional
to the silver concentration,19 this problem can potentially be
addressed by using metallic silver dressings with controlled
release capabilities, allowing for complete wound healing to
occur.20 Ultimately, the desired goal is to achieve an opti-
mized release profile that results in antimicrobial/antibac-
terial efficacy without mammalian cell cytotoxicity.20
The goal of this study was to introduce and evaluate a
new type of high surface area metallic silver in the form of
highly porous silver microparticles (AgMPs). The AgMPs
are composed of AgNP aggregates, resulting in the desired
high surface area without undesired detachment and release
of AgNPs in the environment. These high surface area
AgMPs were incorporated within polylactic acid (PLA)
nanofibrous dressings. Biodegradable, biocompatible PLA
nanofibers, with their morphological similarities to the ex-
tracellular matrix of skin, have great potential to be used as
skin substitutes and wound dressings.21 PLA nanofibers
were loaded with either highly porous AgMPs or AgNPs and
the antimicrobial efficacy and cytotoxicity of the two silver-
based wound dressings were assessed and compared. To
better mimic the physiological environment in vivo where
both human cells and bacteria are present, a novel coculture
system combining human epidermal keratinocytes and Sta-
phylococcus aureus bacteria was designed to simultaneously
evaluate cytotoxicity and antimicrobial efficacy in a three-
dimensional (3D) culture environment. This new coculture




PLA (molecular weight = 70,000 g/mol) was dissolved in
chloroform and dimethylformamide (Sigma) at a ratio of 3:1
to create a 12% solution. AgNPs (20 nm Citrate Biopure
Silver) (Nanocomposix Company) or highly porous AgMPs
(average diameter = 6.9mm, surface area = 3.9 m2/g) (Bio-
Gate AG Company) (Fig. 1) were added to the PLA solution
to obtain a 0.5% concentration of silver to polymer ratio.
Mixtures were stirred on a magnetic stirrer plate for 4 h at
80C and then sonicated for 30 min to further ensure particle
dispersion. Polymer solutions were used immediately after
sonication to eliminate particle precipitation (of particular
importance for AgMPs) and prevent evaporative loss of sol-
vent and the consequent change in solution concentrations.
The PLA solution was electrospun in a custom electrospin-
ning system22 for 2 h using 15 kV voltage, feed rate of 0.7mL/
h, and spinning distance of 13–15 cm. Electrospun scaffolds
were kept under a fume hood overnight to fully evaporate
residual solvents. Scaffolds were then removed from the fiber
collector and cut into circles using a punch (d = 1.6 cm).
Scaffolds were sterilized with 70% ethanol for 10 min, then
rinsed three times with phosphate-buffered saline (PBS), and
soaked in the keratinocyte growth medium (KGM) (KGM-
Gold; Lonza) without antibiotics for 12 h to allow proteins to
attach to the scaffolds. Pure PLA scaffolds containing no
silver were used as controls.
Silver release studies
Scaffolds were soaked in deionized water and incubated
at 37C and 5% CO2 for 1 week. At specific time points, 3, 6,
18, 30, 42, 66, 120, and 168 h, half of the water was removed
FIG. 1. SEM micrograph of the surface of highly porous
AgMPs. AgMPs, silver microparticles; SEM, scanning
electron microscopy.
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and replaced with fresh deionized water. The concentration of
silver ions released at each time point was quantified using
the removed water by means of a Perkin-Elmer AA300
atomic adsorption spectrophotometer (PerkinElmer, Inc.).
Coculture system of human epidermal
keratinocytes with S. aureus
To evaluate the antimicrobial efficacy of AgNP- or
AgMP-loaded scaffolds when seeded with cells, a coculture
system and an experimental process were designed (Fig. 2).
Separate experiments with only human epidermal kerati-
nocytes or S. aureus bacteria were also performed to better
understand and elucidate the results of the coculture system
(Table 1). PLA scaffolds loaded with AgMPs, AgNPs, or
neither (pure PLA, controls) were seeded with human epi-
dermal keratinocytes derived from adult skin (2nd pas-
sage; Lonza) at a density of 4 · 104 cells per scaffold and
incubated for 24 h. The cell-seeded scaffolds were then in-
oculated with 10 CFU/mL S. aureus bacteria (AATCC#
43300) dispersed in 1 mL of keratinocyte growth medium
without antibiotics. Epidermal keratinocyte- and S. aureus-
seeded scaffolds were then placed and maintained in an
incubator (37C, 5% CO2) for 72 h on a rotating plate.
Rotation was incorporated to better mimic body fluid cir-
culation in the wound site and assist with the gradual
movement of bacteria and prevention of their rapid sus-
pension on the nanofibers.23
Monitoring S. aureus growth in coculture system
At specific time points (12, 24, 36, 42, and 72 h), 100mL
of culture medium was taken (after pipetting up and down
several times to ensure bacteria were well suspended in the
medium), diluted multiple times, and spread on Mueller
Hinton agar plates (Thermo Scientific). Agar plates were
incubated overnight to allow bacterial colonies to grow and
become visible to the naked eye for counting and moni-
toring bacterial growth in each well. After 72 h, bacterial
counts were confirmed by the measurement of the optical
density of the bacterial suspension, taken from each sam-
ple, using a UV-Vis spectrophotometer (Biomate3; Thermo
Electron Corporation) at a wavelength of 600 nm.
Human epidermal keratinocyte viability
and proliferation in coculture system
Viability analyses were performed at day 1 (24 h after
keratinocyte seeding on the scaffolds and before addition of
bacteria) and day 3 (72 h after addition of bacteria) using a
fluorescent method (Live-Dead Assay Cytotoxicity Kit for
mammalian cells; Molecular Probes). Specifically, kerati-
nocyte-seeded scaffolds were placed in KGM with the ad-
dition of 4 mM calceinacetoxymethyl ester-AM (staining the
cytoplasm of live cells green) and 4 mM ethidiumhomodi-
mer (staining the nuclei of dead cells red). The samples were
then incubated for 20 min while protected from light. Cell
FIG. 2. Three-dimensional cocul-
ture system to evaluate human skin
and/or other mammalian cells in
combination with bacteria on scaf-
folds/wound dressings. Color images
available online at www.liebertpub
.com/tec
Table 1. Design of Experiment for Antimicrobial and Cytotoxicity Evaluation
of Scaffolds Either Separately or in a Coculture System
Scaffold Replicates Analyses
Cytotoxicity experiment Pure PLA 3 AlamarBlue assay
PLA + AgNPs 3 DNA assay
PLA + AgMPs 3
Antimicrobial experiment Pure PLA 3 Spectrophotometry
PLA + AgNPs 3 Plate count
PLA + AgMPs 3
Coculture experiment Pure PLA 3 Spectrophotometry
PLA + AgNPs 3 Plate count
PLA + AgMPs 3 DNA assay
PLA, polylactic acid; AgMPs, silver microparticles; AgNPs, silver nanoparticles.
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proliferation, in cultures without bacteria, was determined
with a cell viability assay (alamarBlue; AbDSerotec) at
different time points after seeding of cells on scaffolds (days
1, 2, and 3). AlamarBlue, at a volume of 10% of the culture
medium, was added to each well, 7 h before each mea-
surement. After incubation with alamarBlue, 200 mL of each
sample was taken in triplicate and the absorbency read at
600 nm using a microplate reader (TecanGENios; Tecan). A
greater alamarBlue reduction% indicated greater cell pro-
liferation. Since the alamarBlue assay is not an accurate
method to evaluate the proliferation of cells in coculture
systems (the presence of bacteria changes the reduction%),
the number of cells on the scaffolds was quantified by
measuring the DNA content in each scaffold after 72 h. The
scaffolds were washed at least three times with PBS to
confirm that the bacteria were detached from the scaffolds.
To verify that all bacteria were washed out from the scaf-
folds, the PBS solution from the last wash was used for
bacterial analysis to confirm no bacteria were present in the
PBS from the last wash. Once this was confirmed, the
amount of DNA in each nanofibrous scaffold was then
measured with the DNA binding dye Hoechst 33258 in a
microplate format after an overnight digestion at 60C in
2.5 U/mL papain in PBS with 5 mM ethylenediaminete-
traacetic acid and 5 mM cysteine HCl (all reagents from
Sigma).
Microscopic analyses
Keratinocyte morphology on the scaffolds was evaluated
using scanning electron microscopy (SEM) (FESEM JEOL
6400 F) at 15 kV accelerating voltage. At each time point,
nanofibrous scaffolds were fixed in 10% buffered formalin
for 30 min and then dehydrated with a graded concentration
(50–100% v/v) of ethanol. Dehydrated scaffolds were im-
mersed in hexamethyldisilazane for 15 min and dried over-
night in a fume hood. Dried samples were sputter coated
with gold to observe the morphology of cells using SEM.
The transmission electron microscope (TEM) (Hitachi
HF2000) was used to further characterize longitudinal dis-
persion of particles within ultrafine electrospun fibers at
200 kV accelerating voltage.
Statistical analyses
Statistical analyses were performed using SPSS 14.0.
Data were analyzed using the Duncan test with p-values less
than 0.05 considered statistically significant.
Results
Electrospun PLA fibers containing either AgNPs or
highly porous AgMPs formed in a uniform manner on the
fiber collector (Fig. 3a, d). However, as expected, incorpo-
ration of the two particles within the fibers varied. SEM
FIG. 3. PLA nanofibers
containing AgNPs (a–c) or
highly porous AgMPs (d–f).
AgNPs, silver nanoparticles;
PLA, polylactic acid.
FIG. 4. Release profiles of silver
ions from PLA scaffolds loaded with
silver nano- or microparticles. Differ-
ent letters indicate significant differ-
ences between groups (p < 0.05).
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images indicated that AgNPs were not present on the surface
of fibers and there were very few locations where AgNPs
were close to the fiber surface (Fig. 3b). TEM analysis
confirmed the presence of well-dispersed AgNPs inside the
fibers, closer to the core (Fig. 3c). Highly porous AgMPs, on
the other hand, were too large to be encapsulated inside the
nanofibers. SEM (Fig. 3e) and TEM (Fig. 3f) images
showed that these AgMPs were present on the surface of
fibers.
Release profiles revealed that silver ions gradually release
from both scaffolds, doped with AgNPs or highly porous
AgMPs, over a 1-week (168 h) period (Fig. 4). Silver ion
release was slow at the first two time points (3 and 6 h) for
both scaffolds, then significantly accelerated at the 18-h
time point for nanofibers doped with highly porous AgMPs
(Fig. 4). The rate of release and cumulative release remained
greater for scaffolds doped with highly porous AgMPs at all
remaining time points.
AlamarBlue findings indicated that proliferation of kera-
tinocytes was diminished on PLA scaffolds loaded with
AgNPs or AgMPs compared with pure PLA scaffolds, with
lowest proliferation observed for AgNP-loaded scaffolds
(Fig. 5). Similarly, viability analyses indicated that neither
AgNP- nor AgMP-loaded scaffolds supported human epi-
dermal keratinocyte viability after 3 days (Fig. 6). Live/dead
images showed no obvious difference between the viability
of keratinocytes on nanofibers containing either AgNPs or
AgMPs at day 3, but a greater viability of AgMP-loaded
scaffolds relative to AgNP-loaded scaffolds at day 1. Ad-
dition of bacteria to the culture medium further decreased
cell viability for all three keratinocyte-seeded scaffolds
(Fig. 6). SEM micrographs indicated that keratinocytes ad-
hered and spread throughout the pure PLA scaffolds.
However, keratinocyte morphology was clearly different on
PLA scaffolds loaded with AgNPs or AgMPs. On those
scaffolds, the cell number was reduced and cells were
rounded, representing the morphology of dead cells (Fig. 7).
SEM images showed no obvious difference between cells
on nanofibers containing AgNPs or AgMPs. Consistent with
qualitative viability analyses (Fig. 6), SEM images re-
presented that addition of bacteria to the culture medium
further reduced the number of viable cells on pure PLA
scaffolds. SEM images also confirmed the presence of
S. aureus bacteria on all three scaffolds.
DNA quantitation (Fig. 8) indicated that pure PLA scaf-
folds supported the greatest keratinocyte viability relative to
either AgNP- or AgMP-loaded scaffolds in the presence or
absence of bacteria consistent with viability (Fig. 6) and
SEM (Fig. 7) analyses. Similar to the alamarBlue findings
(Fig. 5), DNA content analysis showed higher proliferation
FIG. 5. Human epidermal keratinocyte proliferation on
scaffolds without bacteria in the culture medium. Different
letters indicate significant difference (p < 0.05).
FIG. 6. Viability of human
epidermal keratinocytes on
scaffolds (live cells = green;
dead cells = red). Addition of
AgNPs and AgMPs to nano-
fibers reduced viability of
keratinocytes on these sam-
ples. The presence of bacteria
in cultures also diminished
the number of viable cells on
all three nanofibrous dress-
ings. Color images available
online at www.liebertpub
.com/tec
794 MOHITI-ASLI ET AL.
of keratinocytes in the absence of bacteria on AgMP-loaded
nanofibers compared with AgNP-loaded nanofibers. The
DNA content significantly dropped for pure PLA scaffolds
and scaffolds loaded with AgMPs with the addition of
bacteria to the culture medium. Bacterial analyses indicated
that S. aureus proliferated on all three scaffolds, with the
highest rate of growth for pure PLA scaffolds without ker-
atinocytes (Fig. 9). Although the addition of AgNPs and
AgMPs to the PLA scaffolds reduced the bacterial growth
rate, no significant difference was observed between the
antimicrobial properties of nanofibers containing either
AgNPs or AgMPs. The presence of keratinocytes in cocul-
ture systems with S. aureus further diminished bacterial
growth for cultures with pure PLA nanofibers after 72 h
(Fig. 9).
Discussion
In this study, a new metallic silver compound comprising
highly porous AgMPs was successfully incorporated within
PLA electrospun nanofibers using a conventional electro-
spinning approach. Gradual, sustained release of silver ions
from these scaffolds was observed over a 7-day experimental
period. Interestingly, within 18 h and for all time points
thereafter, the rate of silver ion release was significantly
higher for AgMP-loaded scaffolds relative to AgNP-loaded
scaffolds. This can be related to the different cross-sectional
locations of the two particles within the fibers. Dopants closer
to the outer layer of fibers release faster than those well in-
corporated inside the core (Mohiti-Asli et al., Submitted).
AgNPs located inside the fiber therefore release silver ions
slower than highly porous AgMPs that, by function of their
size, are present at the surface of fibers. As expected, cyto-
toxicity analyses of the AgNP- and AgMP-loaded scaffolds
indicated that keratinocytes do not proliferate as well on
either of these scaffolds relative to their proliferation on
pure PLA scaffolds. Our findings are consistent with previous
investigators who have reported diminished proliferation of
keratinocytes in the presence of silver ions.24–26
In the absence of bacteria in the culture medium, ala-
marBlue and DNA content findings indicated that kerati-
nocytes exhibited a significantly greater proliferation on
AgMP-loaded scaffolds relative to AgNP-loaded scaffolds.
However, with the inclusion of S. aureus bacteria in the
coculture system, there was no significant difference in
keratinocyte cytotoxicity between AgMP or AgNP scaffolds
according to DNA content analyses. These results indicate
that even though the AgMP-loaded scaffolds exhibited a
higher silver ion release rate, their cytotoxicity to kerati-
nocytes was less than AgNP-loaded scaffolds. A limitation
of this experiment was the possibility that, even after mul-
tiple washes and confirmation of no bacteria in the solution,
some residual bacteria remained adhered to the scaffolds.
However, even if this did occur, the same washing approach
was used for all samples and samples were compared with
each other. Therefore, any effects were likely normalized
and not expected to affect conclusions regarding the dif-
ferences between the scaffold types.
As expected, antimicrobial analyses revealed a delay in
the growth of S. aureus bacteria on silver ion release scaf-
folds relative to pure PLA controls. However, the amount of
silver ions released from the two scaffolds was not adequate
FIG. 7. SEM micrographs
of human epidermal kerati-
nocytes seeded on scaffolds
(a, d: pure PLA; b, e: AgNP
loaded; c, f: AgMP loaded)
with (d–f) and without (a–c)
the presence of Staphylo-
coccus aureus at day 3.
Dotted arrow shows the
morphology of live cell,
dashed arrow shows the
morphology of dead cell,
and solid arrows point to
the bacteria.
FIG. 8. Human epidermal keratinocyte DNA quantitation
on scaffolds both in the presence and absence of S. aureus
bacteria at day 3. Different letters indicate significant dif-
ferences between groups (p < 0.05).
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to kill all bacteria within the solution with the initial con-
centration of 10 CFU/mL S. aureus bacteria that was eval-
uated. Although increasing the initial concentration of silver
particles in nanofibers can increase the release of silver ions
(Mohiti-Asli et al., Submitted) and thereby increase their
antimicrobial properties, we would not recommend such an
approach except for severely infected wounds given the cy-
totoxic effects of increased silver concentration on human
epidermal keratinocytes that we have found and reported
here. The rate of bacterial growth over 72 h was not signifi-
cantly different for scaffolds containing AgNPs or AgMPs.
This finding was not unexpected given that while the differ-
ence in silver ion release was statistically significant at most
time points (Fig. 4), quantitatively the difference in silver
release was very slight between the two scaffolds before the
120-h evaluation point. The maximum difference in silver ion
release between the two scaffolds occurred at the 66-h time
point and was equal to 0.042 ug/mL (AgMP-loaded scaffold
silver release = 0.081; nanoparticle-loaded scaffold re-
lease = 0.039; difference = 0.042mg/mL). This difference was
apparently not high enough to result in a significant differ-
ence in antibacterial efficacy between the AgMP- or AgNP-
loaded scaffolds.
To avoid complex interactions between mammalian cells
and bacteria, a majority of previous studies have evaluated
the antimicrobial and cytotoxicity of antimicrobial agents
separately. Such an approach may not appropriately address
the in vivo environment. To address this, some recent studies
have tried to implement two-dimensional, monolayer co-
culture systems of cells and bacteria to test antimicro-
bial agents that can be added to the culture medium.27–30
To date, there is no published method on evaluating anti-
microbial dressings in coculture systems. Therefore, we
designed a novel 3D coculture system to assess the cyto-
toxicity and antimicrobial properties of antimicrobial scaf-
folds/wound dressings in one experiment. The presence of
S. aureus reduced the viability and proliferation of human
epidermal keratinocytes on all three scaffolds (pure PLA,
AgNP loaded, and AgMP loaded). This has been reported
previously by other researchers who studied the interaction
of cells and bacteria in the absence of dressings.30,31 In
addition, the growth of S. aureus bacteria was diminished on
scaffolds seeded with epidermal keratinocytes relative to
acellular scaffolds. This phenomenon is likely attributed to
the release of antimicrobial peptides when the bacteria come
in contact with the keratinocytes.32,33
In conclusion, we have shown that highly porous AgMPs
can be successfully incorporated into nanofibrous wound
dressings, and exhibit comparable antimicrobial efficacy and
cytotoxicity to nanofibrous wound dressings incorporating
AgNPs. Further, PLA nanofibers containing highly porous
AgMPs exhibited steady silver ion release, at a greater rate of
release, than nanofibers containing AgNPs. We propose that
highly porous AgMPs can be used as an alternative to AgNPs
in skin substitutes or wound dressings for infected wound sites.
Future studies should investigate the cytotoxicity of nanofibers
containing different concentrations of AgMPs both in vitro
using skin equivalents,34 which have many morphologic and
phenotypic properties of human skin, and in vivo and assess the
degradation of particles over extended durations.
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